PACIRA BIOSCIENCES, INC. Convertible Debt
PACIRA BIOSCIENCES, INC. (PCRX) had Convertible Debt of $118.53 million as of 2016-09-30, per its 10-Q filed 2016-11-02.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleDebt · last filed 2016-11-02
- 2016-09-30: Convertible Debt $118.53M.
- 2016-06-30: Convertible Debt $118.53M.
- 2016-03-31: Convertible Debt $118.53M.
- 2015-12-31: Convertible Debt $118.53M.
| Period end | Convertible Debt |
|---|---|
| 2016-09-30 | $118.53M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $118.53M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $118.53M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $118.53M 10-Q · filed 2016-11-02 |
| 2015-09-30 | $118.53M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $118.53M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $120.00M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $120.00M 10-Q · filed 2015-10-27 |
| 2014-09-30 | $120.00M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $120.00M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $120.00M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $120.00M 10-Q · filed 2014-10-30 |
| 2013-09-30 | $120.00M 10-Q · filed 2013-10-31 |
| 2012-12-31 | $0.00 10-Q · filed 2013-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |